Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

2-hydroxy-4-(4-(5-(2-methyl-3-phenylprop-2-enylidene)-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl)butanoylamino)benzoic acid MeSH Supplementary Concept Data 2025


MeSH Supplementary
2-hydroxy-4-(4-(5-(2-methyl-3-phenylprop-2-enylidene)-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl)butanoylamino)benzoic acid
Unique ID
C577640
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C577640
Entry Term(s)
ML-145
Registry Numbers
0
Heading Mapped to
*Aminosalicylic Acids
*Thiazolidines
Frequency
2
Note
a GPR35 protein antagonist; structure in first source
Source
J Pharmacol Exp Ther. 2012 Dec;343(3):683-95.
Date of Entry
2013/01/22
Revision Date
2013/01/22
2-hydroxy-4-(4-(5-(2-methyl-3-phenylprop-2-enylidene)-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl)butanoylamino)benzoic acid Preferred
ML-145 Narrower
page delivered in 0.004s